NY Times Corrects Gina Kolata Re: Alzheimer’s
Five weeks after publishing a grossly dis-informative front-page report by Gina Kolata about Alzheimer’s research,The New York Times published a lengthy three paragraph correction.
Research Integrity: Don’t Mess With the DSMB
"The current way that DSMBs are constituted and report has resulted in a loss of faith." NEJM
Anesthesiologist who Committed Major Fraud Claims Bipolar Defense
"He was one of the most prolific investigators in the area of postoperative pain management. His fraud sets back our knowledge in the field tremendously.” Dr. Steve Shafer, the editor in chief of Anesthesia & Analgesia.
Will Another Blockbuster Drug Hit the Dust?
"The vote is an enormous blow to Avandia and GlaxoSmithKline. The vast majority of panel members voted either to withdraw the drug or to allow continued sales only if strict controls are added"
NIH Needs Sunshine Law Enforcement
The dust-up involving Dr. Charles Nemeroff and Dr. Thomas Insell, director of NIMH shines a light on NIH leaders whose failure to enforce federal disclosure requirements is brushed off with excuses so untenable they have the ring of theater of the absurd.
NIH Reform Compromised By Chief NIMH Psychiatrist
"Dr. Nemeroff has become the poster child for what’s wrong with academic medicine in our country." Dr. Thomas Insell, Director of the NIMH, quietly helped him get a prized position at the University of Miami.
New Theory of Alzheimer’s Explains Drug Failures
A stunning admission of failure by major drug manufacturers who market drugs for the treatment of Alzheimer’s. "We really believe drugs are failing because we honestly don’t understand the disease."
“Unhinged: the Trouble with Psychiatry”
"The resulting frenzy of psychiatric diagnoses has damaged the credibility of everyone in the field."
Eli Lilly Exec Heads to Harvard Medical School
"Does this appointment signify that Harvard Medical School intends to even further strengthen its research ties to the pharmaceutical industry?"
JAMA Antidepressant Meta-analysis Reveals 22 Years of Deception
Twenty-two years after the US marketing of Prozac, JAMA meta-analysis shows antidepressants to be worthless for most of the people for whom they are prescribed.
Psychosurgery Promoted by NYT: Here We Go, Again
"Only 3 patients were in remission without adverse effects at long-term follow-up."
84% Americans Blame Big Pharma for Healthcare mess
Big Pharma’s defense for its inequitable U.S. pricing is grounded on a Big Lie